Skip to main content
Premium Trial:

Request an Annual Quote

Mark Boyle

Clinical Genomics has appointed Mark Boyle as president of in vitro diagnostics. Boyle joins Clinical Genomics from Qiagen, where he served as a VP for nearly five years. Previously, he served as president of Cellestis, prior to that firm's acquisition by Qiagen and successful integration into the company. He has also served as general manager for the UK subsidiary of Diagnostics Systems Laboratories.